C

Cyteir Therapeutics

39 employees

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

Basic info

Industry

research services

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2012

Funding rounds raised

Total raised

$80M

from 18 investors over 18 rounds

C

Cyteir Therapeutics raised $80M on February 11, 2021

Investors: CaaS Capital Management, Avidity Partners, Venrock, Osage University Partners (OUP), Novo Holdings, Lightstone Ventures and RA Capital Management, L.P.

C

Cyteir Therapeutics raised $40M on October 15, 2019

Investors: Celgene, Novo Holdings, Venrock, Lightstone Ventures and Osage University Partners (OUP)

C

Cyteir Therapeutics raised $29M on March 8, 2018

Investors: Celgene, Lightstone Ventures, Venrock and Osage University Partners (OUP)

C

Cyteir Therapeutics raised $2M on June 29, 2016

Investors: National Institutes of Health

C

Cyteir Therapeutics raised $5.5M on November 5, 2015

Investors: Celgene

FAQ